Q2 2024 Holdings
Filed 2024-08-14 | 35 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $346.8M | 4,571,678 | 13.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $231.4M | 538,139 | 8.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $212.4M | 3,848,095 | 8.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $204.1M | 5,259,089 | 7.8% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $149.7M | 947,574 | 5.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $121.9M | 2,704,718 | 4.7% |
| Merus N V | COM | N5749R100 | $119.5M | 2,019,814 | 4.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $112.6M | 2,513,302 | 4.3% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $95.3M | 2,330,508 | 3.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $93.5M | 4,539,381 | 3.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $90.6M | 664,307 | 3.5% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $85.5M | 7,903,600 | 3.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $79.7M | 2,043,280 | 3.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $66.2M | 2,435,416 | 2.5% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $65.5M | 1,564,452 | 2.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $64.9M | 2,438,149 | 2.5% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $53.3M | 1,203,308 | 2.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $47.4M | 627,202 | 1.8% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $46.8M | 3,870,594 | 1.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $41.9M | 2,325,449 | 1.6% |
| Immatics N.v(IMTX) | SHS | N44445109 | $39.8M | 3,421,965 | 1.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $37.7M | 2,896,349 | 1.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $36.0M | 1,362,827 | 1.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $30.6M | 3,624,342 | 1.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $27.6M | 1,089,492 | 1.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $26.9M | 1,542,805 | 1.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $17.1M | 7,250,000 | 0.7% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $14.1M | 2,335,926 | 0.5% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $13.0M | 330,000 | 0.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $10.4M | 721,087 | 0.4% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $9.5M | 1,575,605 | 0.4% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $9.2M | 919,692 | 0.4% |
| VOR Biopharma Inc | COM | 929033108 | $6.5M | 6,457,293 | 0.2% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $3.8M | 659,724 | 0.1% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $2.1M | 353,886 | 0.1% |